Genetic polymorphisms in genes including alarmin cytokines (TSLP and IL-33) type 2 cytokines (IL-4, IL-13) and other inflammatory-related proteins (HLA, ADAM33), and vitamin D receptor have been shown to enhance, or reduce, the risk and severity of asthma in individuals. This evidence concerns the gene ADAM33 and asthma.